低FODMAP饮食改善腹泻型肠易激综合征结肠屏障功能与肥大细胞活化
该机制性试验纳入42例罗马IV腹泻型肠易激综合征(IBS-D)患者,评估低FODMAP饮食(LFD)前后屏障功能及肥大细胞变化;34例对LFD有应答。LFD后结肠屏障结构功能、肥大细胞数量及介质水平显著改善,且粪便上清液通过TLR4依赖的肥大细胞活化导致屏障功能障碍。
要点
- LFD可改善IBS-D患者结肠屏障功能障碍及肥大细胞募集与活化。
- LFD后粪便上清液不再诱导小鼠结肠屏障功能障碍。
- FODMAPs通过粪便脂多糖直接激活结肠肥大细胞TLR4受体介导屏障障碍。
核心结论
- IBS-D患者接受LFD后结肠屏障功能障碍、肥大细胞募集和活化均改善。
- FODMAPs介导的IBS-D屏障功能障碍由粪便脂多糖直接激活结肠肥大细胞TLR4受体所致。
研究设计与样本
- 机制性试验,42例罗马IV标准IBS-D患者接受LFD前后评估屏障功能、肥大细胞数量及活化谱。
- 粪便上清液(FS)经结肠内给予野生型小鼠(伴/不伴药物抑制)、tlr4-/-小鼠及肥大细胞缺陷小鼠(伴/不伴肥大细胞重建)。
主要发现
- 42例患者中34例对LFD应答,8例无应答。
- IBS-D患者LFD后结肠屏障结构功能、肥大细胞数量及肥大细胞介质水平显著改善。
- 生理变化幅度与临床应答幅度不相关。
- LFD前粪便定植无菌小鼠导致屏障功能障碍,LFD后粪便则否。
- LFD前FS在野生型小鼠诱导屏障功能障碍,LFD后FS则否。
关键数值与推荐
- 去除脂多糖及拮抗TLR4可逆转LFD前IBS FS诱导的屏障功能障碍。
- tlr4-/-小鼠接受LFD前FS未出现屏障功能障碍。
- 肥大细胞稳定剂处理的野生型小鼠或肥大细胞缺陷小鼠接受LFD前IBS FS未出现屏障功能障碍。
- 肥大细胞缺陷小鼠重建野生型肥大细胞后可诱导屏障功能障碍,重建tlr4-/-肥大细胞则否。
临床怎么用
- LFD是IBS-D有效饮食疗法,其机制涉及改善结肠屏障及肥大细胞活化。
- TLR4/肥大细胞轴可能为IBS-D治疗靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (LFD) is the most efficacious dietary therapy for irritable bowel syndrome (IBS). However, the mechanisms by which fermentable oligosaccharides, disaccharides, monosaccharides, and polyols drive IBS pathophysiology are unclear. METHODS: Patients with Rome IV diarrhea-predominant IBS (IBS-D) underwent barrier function evaluation pre- and post-LFD along with assessment of mast cell number and activation profile. Finally, fecal supernatants (FS) were administered intracolonically to wild-type mice with and without pharmacologic inhibition, toll-like receptor 4 (tlr4)-/- mice, and mast cell-deficient mice with/without mast cell reconstitution. RESULTS: Of 42 patients, 34 responded to the LFD and 8 did not. Patients with IBS-D had significant improvement in colonic barrier structure and function, mast cell number, and levels of mast cell mediators post-LFD. The magnitude of physiological changes did not correlate with the magnitude of clinical response. Humanization of germ-free mice with pre-LFD feces caused barrier dysfunction and post-LFD feces did not. Similarly, pre-LFD FS caused barrier dysfunction in wild-type mice, whereas post-LFD FS did not. Lipopolysaccharide removal and TLR4 antagonism reversed pre-LFD IBS FS-induced barrier dysfunction. Barrier dysfunction was absent in tlr4-/- mice treated with pre-LFD FS. Similarly, pre-LFD IBS FS did not cause barrier dysfunction in wild-type mice treated with mast cell stabilizer or in mast cell-deficient mice. However, barrier dysfunction was inducible in mast cell-deficient mice upon reconstitution with wild-type mast cells, but not tlr4-/- mast cells. CONCLUSIONS: Patients with IBS-D exhibited improvement in colonic barrier dysfunction, mast cell recruitment, and activation post LFD. Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols-mediated barrier dysfunction in IBS-D is mediated by direct activation of the TLR4 receptor on colonic mast cells by fecal lipopolysaccharide. CLINICALTRIALS: gov, Number: NCT04542018.
引用
- Gao J, Lee AA, Abtahi S, et al. Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet Improves Colonic Barrier Function and Mast Cell Activation in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Mechanistic Trial. Gastroenterology. 2025. PMID: 40749856. doi:10.1053/j.gastro.2025.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。